The continuous tracking of operational health across an investment portfolio, as opposed to point-in-time diligence. Portfolio monitoring surfaces early warning signals, benchmarks companies against peer cohorts, and prioritizes operating-partner attention. Zoe’s portfolio view refreshes weekly.
Traditional portfolio monitoring relies on quarterly board reports and fiscal year-end results—a lag that makes intervention slow and reactive. By the time a board meeting surfaces a problem, three months have passed. Continuous behavioral monitoring enables weekly or daily visibility into operational health, surfacing problems weeks before they show in financial statements. This velocity difference is material: a company caught in a decision-velocity decline in week one can be corrected through process change; by week twelve, the culture and talent have already degraded. Firms that operate portfolio monitoring at weekly cadence typically achieve 200–400 basis points higher IRR than those relying on quarterly check-ins, because operating partners can intervene early rather than perform triage.
Zoe's Portfolio Monitoring dashboard tracks all nine health dimensions across every portfolio company, refreshed weekly and benchmarked against peer cohorts. Each company receives a Zoe Score (0–100) and a color-coded health status indicating which dimensions require attention. The system also highlights early warning signals triggering across the portfolio, enabling operating partners to triage. Monitoring data feeds into the early-warning-signal framework, identifying company-specific risks (a CTO under retention pressure) and portfolio-wide patterns (attrition pressure across the cohort). The output is a continuous operating intelligence layer that complements—not replaces—board reporting, enabling faster intervention cycles and better decision velocity during the hold period.
You have a deal on the table. Run a Zoe diagnostic before you sign.
Join 200+ firms on the waitlist
